Lead investigational asset vidutolimod is a potential best-in-class TLR9 agonist, with demonstrated clinical responses observed in PD-1 refractory melanoma as monotherapy Vidutolimod is currently ...
In the first ever disclosure for the subcutaneous formulation of Opdivo, the CheckMate -67T Phase 3 trial demonstrates activity in advanced or metastatic clear cell renal cell carcinoma Company plans ...
The Peacemaker Season 2 finale had some shocking moments, including a finale that saw the titular hero very far from home. However, it also introduced a new covert organization straight out of DC ...
The dust has barely settled on the basic version of the new Checkmate stealth fighter jet, but Russian defense giant Rostec is already teasing the plane’s upcoming advanced variants. The report ...
Proposed ~$250 million all-cash acquisition strengthens Regeneron's portfolio of diverse and combinable immuno-oncology candidates Lead investigational asset vidutolimod is a potential best-in-class ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback